Quanta, a pioneering medical devices company, has developed advanced haemodialysis systems for use in the home and clinic.
Quanta is focused on the commercialisation and ongoing development of SC+, an innovative cartridge-based haemodialysis system.
SC+ is a high performance, compact haemodialysis system providing clinical efficacy by utilising typical flow rates of traditional in-centre machines.
SC+ supports the entire ‘Continuum of Care’ for dialysis patients, from nurse-assisted treatment through self-care in centre to home haemodialysis.
Our system facilitates the seamless transition between treatment modalities providing the best tool to enable flexibility for patients, and treatment options for physicians.
Quanta’s unique approach to dialysis is addressing a large and rapidly growing global need:-
- 3.0 million dialysis patients worldwide in 2015
- Estimated to grow to 4 million by 2020
- 24,166 patients in the UK alone during 2014
SC+ combines the advantages of an easy-to-use system with the performance and flexibility to match the typical dialysis provided by larger clinical machines.